All In MedTech

Device Trial Radar · NCT04320823

IMPACT (Improving Plasma Collection) Clinical Trial

Prospective, Randomized, Controlled, Multicenter Clinical Trial to Demonstrate the Safety and Effectiveness of the NexSys® PCS Plasma Collection System With the Percent Plasma Nomogram (PPN) Feature

Last checked: Nov 19, 2026Latest source record: Apr 9, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 3,443 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

3,443

Actual

Start

Jan 6, 2020

Primary completion

Mar 27, 2020

Study completion Apr 27, 2020

Sponsor

Lead sponsor
Haemonetics CorporationPublic (HAE)
Sponsor type
Industry
First posted
Mar 25, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 66 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Prospective, multi-center, randomized, controlled clinical trial to study the safety and effectiveness of a novel plasma collection system software.

Conditions

  • Apheresis Related Hypotension

Interventions

  • Updated Plasma Collection FeatureDevice

    Plasma collection using a novel, patented system that supports a more individualized collection approach.

  • Current Plasma Collection ApproachDevice

    Plasma collection using the current collection approach.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of Significant Hypotensive Adverse EventsTime frame: Up to approximately 3 months (total trial duration during which donors could donate), depending on time of enrollment into the trial.

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Octapharma Plasma

    Wichita, Kansas

  • Octapharma Plasma

    Charlotte, North Carolina

  • Octapharma Plasma

    Spokane, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.